KAER Biotherapeutics
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
- Medical device or technology
- Other R&D services
KAER Biotherapeutics offers AeroPulsR and SUPRAER-Clinic, advanced aerosol systems delivering high-dose, fine-particle therapeutics to distal lungs in NICU, PICU, ICU, and emergency settings.
Our patented technology ( 22 Issueed, 5 Pending) supports viscous, complex structures drugs, targeting growing markets: antibiotics ($2.2B), pulmonary surfactants ($800M), and animal respiratory health ($9B). KAER seeks partners to license and commercialize globally.
More Details on KAER's Website
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}